Director, Regional Marketing Lead – Lung, Head & Neck, Gi Cancers And Subcutaneous Launch

Role Overview Our Oncology organization is dedicated to delivering breakthrough innovations that extend and improve the lives of people with cancer across Asia Pacific. We are focused on translating breakthrough science into meaningful customer solutions, expanding access to innovative medicines, and delivering strong execution across priority oncology brands and indications. The Director, Regional Oncology Marketing Lead – Lung, Head & Neck, GI Cancers and Subcutaneous Launch is a key regional commercial leadership role responsible for shaping franchise strategy, brand planning, portfolio prioritization, forecasting, and lifecycle strategy across assigned tumour areas and the subcutaneous launch. The role partners closely with markets, cross-functional regional teams, and global stakeholders to identify growth opportunities, anticipate market challenges, inform investment choices, and strengthen long-term portfolio value. The role requires strong strategic thinking, business judgment, analytical discipline, and cross-functional leadership. The incumbent will translate market insights, competitive intelligence, access realities, customer needs, and financial assumptions into clear strategic recommendations, actionable brand plans, and high-quality business decisions across Asia Pacific. What will you do: Owns regional franchise strategy, brand planning, and portfolio priorities across assigned lung, head & neck, GI cancer indications and the subcutaneous launch. Leads strategic planning, long-range planning inputs, forecasting assumptions, performance reviews, and opportunity assessments in partnership with country teams and cross-functional stakeholders. Identifies key growth opportunities, market challenges, access risks, competitive threats, conversion barriers, and strategic business questions requiring regional leadership. Balances regional strategic direction with local market adaptation across diverse Asia Pacific market environments, particularly across large mature markets, access-constrained markets, and fast-evolving competitive landscapes. Requires strong matrix leadership across commercial, medical, market access, policy, analytics, finance, regulatory, supply, global teams, and country leadership. May include responsibility for guiding, coaching, and prioritizing the work of marketers or project teams supporting assigned priorities. 1) Franchise Strategy and Brand Planning Lead the annual strategic planning and brand planning processes for assigned lung, head & neck, GI cancer indications and the subcutaneous launch across Asia Pacific. Translate portfolio priorities into clear strategic choices, customer priorities, brand objectives, subcutaneous conversion priorities, and market-level planning guidance. Identify key growth opportunities, market access challenges, competitive threats, guideline changes, biomarker dynamics, customer needs, treatment adoption barriers, and business risks across priority markets. Develop strategic recommendations on indication prioritization, sequencing, market focus, investment choices, resource allocation, and launch acceleration priorities. Lead regional strategic planning workshops, brand plan reviews, launch planning discussions, and market business reviews to align priorities and strengthen plan quality. 2) Business Planning, Forecasting and Opportunity Assessment Lead regional inputs into long-range planning, annual budget, forecasting, and demand planning processes for assigned lung, head & neck, GI cancer franchises and the subcutaneous launch. Consolidate, challenge, and refine key market assumptions, including epidemiology, patient flow, treatment rates, biomarker testing, access timing, market share, duration of therapy, conversion assumptions, and competitive impact. Assess evolving treatment landscapes, clinical readouts, competitor activity, guideline updates, reimbursement dynamics, subcutaneous adoption drivers, and major congress data to identify business implications. Identify priority growth opportunities, market challenges, access barriers, competitive threats, under-penetrated segments, and subcutaneous launch acceleration opportunities by market and indication. Monitor business performance against forecast and prepare leadership updates, business cases, scenario plans, and investment recommendations to support decision-making and resource allocation. 3) Launch and Lifecycle Strategy Lead regional launch strategy for new indications, lifecycle opp…